OMPI), a dermatology products maker, for about $344 million. Montreal-based Valeant will pay $19.75 per share in cash for Obagi's stock, a 28 percent premium over the Long Beach, California-based company's closing …
MONTREAL, March 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and …
Valeant Pharmaceuticals
Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced the pricing of the secondary public offering of 2,690,244 shares of its common …
“Their success in the stock picking competition is a testament to LMU’s mission ... Matthew Claflin, Dibyendu Meher, Clifford Ompi, Steven Stergar and David Swiatkowski.
The descriptive research takes stock of what measures the EU has undertaken since ... judgements in the two …
Dr. Obagi and Stonington received approximately $3,288 and $17,863 for 18,375 and 99,840 shares of Series A preferred stock and the related accrued ... This excerpt taken from the OMPI 10-K filed Mar 15, 2007. …
Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes. All other quotes are delayed by at least 15 minutes unless otherwise stated.
Medical device
Also, Buffett said he learned earlier this month that Sokol bought nearly 100,000 shares of Lubrizol stock before recommending that Berkshire buy the chemical ... (CEPH), (DRRX), (ENDP), (IPXL), (ISPH), (OMPI), (PCRX), …
Inc. (OMPI) 4/25/2013 11:21:05 AM Valeant Pharmaceuticals International (VRX) Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of …
Drug stocks: Cantor Fitzgerald launches Buy rated coverage on Forest Labs (FRX) ($36 price target), Obagi Medical (OMPI) ($12), and Salix Pharmaceuticals ... picks up the online restaurant reservation stock at a …